Prentice Capital Management, LP Pet Iq, Inc. Transaction History

Prentice Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$24.99 - $38.45 $3.63 Million - $5.58 Million	-145,110 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$29.04 - $37.49 $5.59 Million - $7.22 Million	-192,612 Reduced 57.03%	145,110 $4.78 Million
Q2 2020 Aug 14, 2020	SELL	$20.16 - $34.84 $12.3 Million - $21.2 Million	-608,401 Reduced 64.3%	337,722 $11.8 Million
Q1 2020 May 15, 2020	BUY	$16.59 - $34.94 $2.67 Million - $5.62 Million	160,886 Added 20.49%	946,123 $22 Million
Q4 2019 Feb 14, 2020	BUY	$22.24 - $27.56 $17.5 Million - $21.6 Million	785,237 New	785,237 $19.7 Million

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Prentice Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prentice Capital Management, LP with notifications on news.